Inhalon Biopharma, Inc.
Biotechnology company · Carrboro, North Carolina, United States
Inhalon Biopharma, Inc. is a biotechnology company headquartered in Carrboro, North Carolina, United States. Its earliest recorded incorporation is in 2018. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $13 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $2.9 million sold in a notice filed in 2020.
Inhalon Biopharma at a glance
What does Inhalon Biopharma do?
US government research funding
7 SBIR/STTR small-business research awards from US health agencies, $12.8 million in total (2022 to 2025). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $2.9 million sold (2020).
Frequently asked questions about Inhalon Biopharma
Where is Inhalon Biopharma headquartered?
Inhalon Biopharma, Inc. is headquartered in Carrboro, North Carolina, United States.
What does Inhalon Biopharma do?
Inhalon Biopharma, Inc. is a biotechnology company.
When was Inhalon Biopharma founded?
The earliest incorporation on record for Inhalon Biopharma, Inc. is in 2018, according to public company registers.
Similar companies
- Mucommune, LLCCarrboro, North Carolina, United States
- LabVoice Inc.Carrboro, North Carolina, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences